Cystic fibrosis

Home
Keys to Success in Medicine
Cardiovascular System
Respiratory System
Locomotor System
Endocrine and Metabolic System
Kidneys and Urinary System
Gastrointestinal Tract
Central Nervous System
Haematological System
Integumental System
Reproductive and Genital System
Recommended Reading
Forum
Links

amazon astore

ydr

aces for paces

Clinical Skills Blogspot

 

Google
Web ydr.org.uk
acesforpaces.com medicalrevision.org

 

 

Cystic Fibrosis    

Title               

Ñ    Cystic Fibrosis

Definition

Ñ    Inherited disease

Ñ    That causes alteration in the

Ñ    Tenacity and viscosity of mucous

Ñ    Produced by epithelial surfaces

Aetiology

Ñ    Autosomal recessive inheritance

Ñ    Gene mutation on the long arm of chromosome 7

Pathogenesis

Ñ    Failure of opening of chloride channels in response to elevated cyclic AMP

Ñ    Results in less salt and water in mucous making it thick and tenacious

Clinical Features

History

Ñ    Presents in childhood or early adult life

RS

Ñ    Sinusitis

Ñ    Nasal polyps

Ñ    Bronchopulmonary infections

Ñ    Breathlessness

Ñ    Haemoptysis

Examination

E&M

Ñ    Nutritional failure

Ñ    Diabetes mellitus

IS

Ñ    Clubbing

RS

Ñ    Bronchiectasis

GIT

Ñ    Meconium ileus:

Infancy

Ñ    Meconium ileus equivalent syndrome (MIE):

Later in life

Ñ    Pancreatic insufficiency

Ñ    Cirrhosis

Ñ    Gallstones

Ñ    Increased incidence of peptic ulcer

Ñ    Increased incidence of gastrointestinal malignancy

RAG

Females

Ñ    Delayed puberty

Ñ    Secondary amenorrhoea

Ñ    Able to conceive

Males

Ñ    Delayed puberty

Ñ    Usually infertile:

Failure of development of vas deferens and epididymis

LMS

Ñ    Delayed skeletal maturity

Ñ    Arthropathy

Complications

CVS

Ñ    Cor pulmonale

RS

Ñ    Pneumothorax

Ñ    Respiratory failure

Investigations

Fluids

Sweat

Ñ    High sweat sodium concentration:

> 60 mmol/L

Blood

Genetics

Ñ    DNA analysis

Biochemistry

Ñ    Trypsin levels:

Useful for screening

Imaging

Chest X-ray and CT scan of chest

Ñ    Changes of bronchiectasis

Management

Control

Drugs

Ñ    Antibiotics:

For chest infections

Ñ    Reduce inflammation:

Inhaled antibiotics and steroids

Ñ    Increase hydration of secretions:

·          Amiloride

·          Trphosphate nucleotide:

Adenosine or uridine triphosphates-ATP or UTP-stimulate nucleotide receptors independent of cAMP

Ñ    DNAase:

Inhaled DNAase breaks down DNA from dead cells

DNA contributes to increased viscosity of sputum

Staffing

Ñ    Physiotherapy:

Clear secretions

Support

Drugs

Ñ    Pancreatic insufficiency:

Pancreatic supplements

Biological Agents

Ñ    Lung transplantation

Ñ    Heart-lung transplantation

Lifestyle Adjustments

Diet

Ñ    Nutritional support

Prevention

Lifestyle Adjustments

Ñ    Genetic screening

Prognosis

Ñ    Prognosis has improved

Ñ    Median survival for those born after 1990 is estimated at 40 years

Back ] Up ] Next ]

 

 

[Up]